Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000097

President and CEO sold 18,333 shares at an average $49.76 ($912,176)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-01 Sale : show line 1 in the form −1,659 $48.61 $80,644 2,138,375 I
2021-11-01 Sale : show line 2 in the form −16,674 $49.87 $831,532 2,121,701 I
Open-market sales · 18,333 sh · avg $49.76 · $912,176
Loading xslF345X03/wf-form4_163597513221470.xml…